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Summary: An improved, specific and sensitive method for the determination of the coproporphyrin isomers I and III
is described. In this method, the hydrolysis of the coproporphyrin methyl esters takes place in the silica gel layer of
acid-resistant pre-coated thin-layer plates. After chromatography in the solvent system 2,6-dimethylpyridine/water
(volume ratio 20 ml + 6 ml), in an ammonia atmosphere, the isomers are measured, either directly in the silica gel
layer by fluorimetry, or after elution in 1.0 mol/1 hydrochloric acid. The technique makes analysis in the nanogram
range possible.
The following fractions of isomer III (%) were found in the urine of healthy subjects and patients with disorders of
prophyrin metabolism ( ± s; n):
Controls 77.5 ± 6.4(15) Congenital erythropoietic porphyria 17.4 (1)
Acute intermittent porphyria 87.3 ± 9.6 (6) Erythropoietic protoporphyria 49.2 ± 8.7 (5)
Porphyria cutanea tarda 67.1 ± 1 1.7 (16) Lead poisoning 95.0 ± 4.6 (4)
Trennung der Koproporphyrin-Isomeren I und HI durch Dünnschichtchromatographie
Zusammenfassung: Es wird eine verbesserte, spezifische und empfindliche Methode zur Bestimmung der Koproporphy-
rin-Isomere I und III beschrieben, bei welcher unter Verwendung von säurefesten Kieselgel-Fertigplatten die Hydro-
lyse der Koproporphyrinmethylester in der Kieselgelschicht erfolgt. Nach Chromatographie im Lösungsmittelsystem
2,6-Lutidin- Wasser (Volumina 20 ml + 6 ml) in Ammoniakatmosphäre werden die Isomere entweder direkt-fluoro-
metrisch (im Kieseigelchromatogramm) oder spektrophotometrisch nach Elution in l ,0 mol/1 Salzsäure gemessen. Das
Verfahren erlaubt eine Analyse im Nanogramm-Bereich.
Im Urin von Gesunden und Patienten mit Porphyrinstoffwechselstörungen wurde folgender AnteiLdes Isomers III (%)
ermittelt: ("x ± s; n):
Kontrollen 77,5 ± 6.4(15) congenitale erythropoetische Porphyrie 17.4 (1)
akute intermittierende Porphyrie 87,3 ± 9,6 (6) erythropoetische Protoporphyrie 49,2 ± 8,7 (5)
Porphyria cutanea tarda 67,1 ± 1 1,7 (16) Bleivergiftung 95,0 ± 4,6 (4).
Indroduction:
The analysis of the coproporphyrin isomers is fundamen- differences in the distribution of the coproporphyrin
tal to further progress in the study of the biosynthetic isomers in urine.
pathways of the isomer series I and III, and the patho- . .
 r .\ y . - . - i. j. j * · In principle, the separation of the coproporphyrin
chemistry of porphyrm metabohc disorders. It is dso J^
 siHca chr0matography goes
needed for the diagnosis of these diseases especially the
hepatic and erythropoietic porphynas and lead poisoning. -u j - me
^ · ·* * r r j r on the paper Chromatographie method described m 1958
Comparison of the literature values for the copropor- byEriksen (2). A solvent system containing 2,6-dimethyl-
phyrin composition of both normal urine (Tab. 1) and pyridine was used in both techniques. Various research
porphyric urine (Tab. 2) reveals some considerable groups have used the Jensen method and modified indi-
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Tab. 1. Coproporphyrin isomers I and III in normal urine.
Author(s) Number of Amount of Reference
subjects copropor- (No..)
(n) phyrin III
Aziz, M. A. et al.
(1964)
Koskelo* P. & Toi-
vonenj. (1966)
Koskelo, P. et al.
(1967)
Koskelo, P. & Toi-
voneu,L (1968)
Ben-Ezzer, J. et al.
(1971)
31 (Adults) 65
9 (children) 81
18 77.4
30 78.2
20 80
62 71-76
3
5
17
18
9
(Papers from the years 1934 to 1963, which for the most part gave
no numerical indication of the isomer distribution, are not inclu-
ded here. Almost all the earlier authors found more of the III
isomer than the I isomer.)
worked on the development of a practical method which
is less troublesome and time-consuming than the origi-
nal. The goal of this work is to work out a specific and
precise method for the biochemical diagnostician. It
should not require much equipment, should be very
sensitive and give a good separation, and should be
suitable for routine urine tests. The method of hydroly-
zing the coproporphyrin methyl esters in the silica gel
after application to the thin-layer plate proved to be
especially advantageous. In this method, the silica gel
layer is thus first used as a reaction system for a chemi-
cal transformation, which is then followed by the
separation of the hydrolyzed substances.
The determination is preceded by thin-layer Chromato-
graphie separation of the porphyrins according to the
number of carboxyl or methylester groups in the mole-
cule. The total amount of coproporphyrin methylester
so obtained (12) is determined spectrqphotometrically
before the isomer analysis is carried out.
vidual steps of it (3-10). The small difference in the
migration velocities of the two isomers limits the amount
of coproporphyrin mixture which can be separated.
Other critical factors in the technique are the quality of
the dimethylpyridine, the composition of the solvent
system, the amount and concentration of ammonia used,
the saturation of the chromatography chamber, and the
method of sample preparation. These observations,
together with the fact that the method for the separation
of the coproporphyrin isomers was frequently varied,
indicate the difficulties which are inherent in the analysis
of the coproporphyrin isomers. A simplified, standar-
dized and optimalized system for the separation of the
coproporphyrin isomers has not yet been published.
Since our first communication in 1967 (11), we have
Materials and Methods
Samples
Urine samples collected over a 24-hour period from clinically
healthy subjects of all ages were examined. The urine of patients
with various disorders of porphyrin metabolism were also
examined. They included the following:
acute intermittent porphyria,
chronic hepatic porphyria,
porphyria cutanea tarda,
congenital erythropoietic porphyria,
erythropoietic protoporphyria, and
porphyrin elimination after oral loading with -aminolevulinic
acid.
Sample preparation
The urine samples were shielded from light and kept cool
during the collection period, and were worked up according
Tab. 2. Coproporphyrin isomers I and III in the urine of patients with disorders of porphyrin metabolism
Author(s) Disease Number Fraction of Reference
of cases coproporphyrin III
(n) (%) (No.)
Chu, T. C. & Chu, E. J.-H. (1967)
Chu, T. C & Chu, E. J.-H. (1967)
Chu, T. C. & Chu, E. J.-H. (1967)
Chu, T. C & Chu, E. J.-H. (1967)
Chu, T. C & Chu, E. J.-H. (1967)
Chu, T. C. & Chu, E. J.-H. (1967)
Dowdle, E. et al. (1970)
Nacht, S. et al. (1970)
Chu, T. C. & Chu, E. J.-H. (1967)
Watson, C. J. (1936)
Vigliani, E. C. & Waldenström, J. (1937)
. Vigliani, E. C. & Libowitsky, H. (1937)
Chu, T. C. &Chu, E. J.-H. (1967)
Chu, T. C & Chu, E. J.-H. (1967)
Chu, T. C. & Chu, E. J.-H. (1967)
Chu, T. C & Chu,£. J.-H. (1967)
Romeo, G. & Levin, E. Y. (1969)
Acute intermittent porphyria —
Acute intermittent porphyria 5
Hereditary coproporphyrinuria 2
Porphyria variegata 2
Porphyria cutanea tarda —
Porphyria cutanea tarda 10
Porphyria cutanea tarda 12
Porphyria cutanea tarda 7
Hexachlorobenzene porphyria 4
Lead poisoning 3
Lead poisoning 10
Lead poisoning 1
Lead poisoning -
Lead poisoning 2
Congenital erythropoietic porphyria -
Congenital erythropoietic porphyria 1
Congenital erythropoietic porphyria 5
80-90
75-85
30-65
ca. 65
50-80
ca. 50
ca. 50
70-75
90-95
nearly all III
nearly all III
mostly ill
90-95
I>III
15
much I
6
19
19
19
6
19
7
20
19
21
22
23
6
19
6
19
24
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to the method previously described (12, 13). The copropor-
phyrin methyl esters were eluted from the silica gel of the thin-
layer plate with chloroform. After evaporation of the solvent,
the samples were stored at ~20°C until isomer analysis could
be carried out.
Reagents
Acid-resistant silica gel thin-layer plates (G 1500, Schleicher &
Sch ll, D-3354 Dassel, Krs. Einbcck).
The plates (200 mm X 200 mm) were cut into strips about
70 mm wide with a glass cutter.
Chloroform p.a. (Merck 2445);
25% Hydrochloric acid, p.a. (Merck 316);
Hydrochloric acid, 1 mol/1, p.a. (Merck 9057);
Acetone p.a. (Merck 14);
Ammonia, 25% (minimum), p.a. (Merck 5432);
2,6-Dimethylpyridine (lutidine), 98% (Roth, Fluka, Koch-
Light): Due to its extreme sensitivity to oxidation, dimethyl-
pyridinc must be redistilled before each chromatography series.
Equipment
Micropipets, 10 μΐ, (Camag);
Round glass development chambers (200 X 100 mm) from
Riedel-de H en (can be obtained from Garquoin & Reuter,
645 Hanau); 50-ml beakers (tall);
15-ml centrifuge tubes (Schott No. 2060111);
Spectrophotometer.
A u t h e n t i c substances for comparison
Coproporphyrin I and III were obtained as the methyl esters
from Koch-Light and Calbiochem. They were also isolated from
microbial cultures grown in the presence of δ-amino-levulinic
acid (12).
Ill
I
Methods
Hydrolysis of the coproporphyrin methyl esters
A small amount of coproporphyrin methyl ester (20-700 ng)
is dissolved in a few drops of chloroform and applied to an
acid-resistant silica gel thin-layer plate with a Camag micro-
pipet. After the chloroform has evaporated, the tetramethyl
ester is hydrolyzcd by dropping 25% HC1 onto it with a Camag
micropipet. The optimum volume of HC1 for the hydrolysis
is 0.3 ml for 20-100 ng coproporphyrin methyl ester. For more
than 100 ng substance, 0.3 ml HC1 per 100 ng coproporphyrin
methyl ester should be used. After each application of the
hydrochloric acid, the silica gel layer must dry in the air. The
total hydrolysis time should always be at least 3 h at room
temperature.
Chromatography
Prerun
To transform the round applied spot into a straight, sharp
starting line, the plate is run twice in a round chromatography
chamber in the solvent system 1 mol/l hydrochloric acid +
acetone (volumes 20 ml and 50 mi). Afterwards the plate is
dried under a hair dryer.
Separation of the isomers
2,6-dimethyl pyridine (20 ml) and distilled water (6 ml) aie
carefully mixed in a Riedel chamber. Then a 50-ml beaker
containing 10 ml 25% ammonia solution is placed in the
chamber. The optimum time for saturation is 15 min. Then the
completely dry silica gel plate can be placed in the solvent.
One must be careful to place the plate with its back (the
glass side) toward the ammonia beaker.
Elution of the free coproporphyrin acids I and III
The coproporphyrin isomers I and III are marked on the
chromatogram under long-wave UV light (366 nm). Copro-
porphyrin III is the faster migrating substance (Fig. 1 and 2).
Fig. 1. Silica gel thin-layer chromatogram of the coproporphyrin
isomers I and III from the urine of a patient with acute
intermittent porphyria.
The separation of the isomers was done in the solvent
system 2,6-dimethylpyridine/water (volumes 20 ml + 6 mi)
in an ammonia atmosphere.
The fluorescent silica gel regions are scraped off the glass with
a scalpel, transferred to a centrifuge tube, and extracted with
1.00 ml of 1 mol/l hydrochloric acid. The coproporphyrins
are immediately eluted by briefly shaking the tube.
Spectrophotometric measurement
After centrifugation of the samples (1200^, 5 min), the absorp-
tion of the eluate is measured in a Spectrophotometer against
1 mol/l hydrochloric acid between 650 and 380 nm (Fig. 3).
(The silica gel itself has no absorption.) The absorption maxi-
mum of the Soret band of the coproporphyrins I and III is at
401.5 (401-402) nm. The secondary peaks are at 590 (I) and
548 (ID nm.
Calculation of the concentrations of the coproporphyrin isomers
The corrected extinction Ecorr = 2 X Emax - (E380+ E430) is
calculated from the general correction formula for the Soret
maximum of the free porphyrin acids (14). The percentage of
coproporphyrin I and III is determined from the sum of the
corrected extinctions. The quantity of the isomers can also
be calculated from the amount of the total coproporphyrin
methyl ester, which was determined before the beginning of
the isomer analysis (11, 12).
Fluorimetric measurement
As an alternative to the Spectrophotometric analysis, the
coproporphyrin isomers can also be determined in situ, that is,
directly in the thin-layer chromatogram, by fluorimetry (15).
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III
I
Fig. 2. Silica gel thin-layer chromatogram of the coproporphyrin
isomers I and III from the urine of a patient with porphy-
ria cutanea tarda. For the solvent system, see the legend to
Fig. 1.
^χ-ΠΙ in
lead intoxication
Λ in porphyria
cutanea tarda
400 500 600 w 400
λίηιϋ]—*-
500 600
Fig. 3. Dicationic spectra of the free coproporphyrinic acids:
Isomer I (-) and isomer III (.-.-) as test substances (A)
compared to coproporphyrin isomer I (-) from porphyria
cutanea tarda and coproporphyrin isomer III (.-.-) from
lead poisoning.
Technical sources of error
1. The hydrolysis time can be lengthened at will, but it must
not be shortened. Too little hydrolysis reagent or too short
an hydrolysis time, like incomplete drying of the silic'a gel
layer after each drop of hydrochloric acid, will cause a
separation of the coproporphyrins into as many as eight
different bands, which have not yet been identified. In any
case they are coproporphyrins: free isomeric acids, and
probably partially esterified coproporphyrins. For the same
reason, the working temperature should not exceed 25 °C,
so that the hydrolysis time is not shortened.
2. The thin-layer plate is completely dry when it looks homoge-
neous in transmitted light. If the plate is not completely
dried after the prerun, the separation of the isomers, which
probably depends on the formation of ammonium chloride,
is hampered.
3. 2,6-Dimethylpyridine oxidizes very easily. For perfect
chromatography, the dimethyipyridine must be distilled
before use and stored in light-protected bottles under
nitrogen gas.
4. If the ammonia solution is spilled from the beaker into the
2.6-dimethylpyridine/water system, the isomers cannot be
separated.
5. Fresh solvents must always be used for a good separation.
6. If the separation is not optimal, rechromatography in the
same solvent system with about 30 ml 25% ammonia solu-
tion (see above) is recommended.
Results
The results obtained in the analysis of the coproporphy-
rin isomers in urine by thin-layer chromatography on
acid-resistant, pre-coated plates with the solvent system
2,6-dimethylpyridine/water are given in Table 3.
The specificity is primarily based on the thin-layer Chro-
matographie isolation and spectrophotometric analysis
of the coproporphyrin methyl ester (12). This copro-
porphyrin methyl ester is subjected to hydrolysis and to
chromatography of the biochemically and diagnostically
relevant isomers I and III. The specificity is secondarily
based on the separation procedure, which was tested
with the pure compounds, and the spectrophotometric
analysis of the free coproporphyrin acids I and HI,
whose spectra, unlike those of the methyl esters, have
a dicationic form (Fig. 3).
The accuracy of the method was tested by recovery
experiments after hydrolysis and chromatography.
There was no significant loss of one isomer compared
to the other in the course of the analysis. Both isomers
were 89% recovered (n = 12, CV = 6%).
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Tab. 3. Coproporphyrin isomers I and III in urine. Results from
analytical thin-layer chromatography.
Number of
subjects
(n)
1. Controls 15
2. Acute intermittent porphyria 6
3. Chronic hepatic porphyria
Type A 4 ·
Type B 4
Type C 4
4. Porphyria cutanea tarda 16
5. Congenital crythropoietic porphyria 1
6. Erythropoietic protoporphyria 5
7. Lead poisoning 4
8. Oral loading with δ-aminolevulinic 4
Fraction of
copropor-
phyrin III
(x ± s in %)
77.5 ± 6.4
87.3 ι 9.6
81. 0 ± 10.7
77.2 ± 8.3
68.0 ± 9.1
67.1 ± 11.7
17.4
49.2 ± 8.7
95.0 ± 4.6
93.5 ± 4.1
acid (12 mg/kg body weight) in
control subjects
9. Oral loading with δ-aminolevulinic
acid (12 mg/kg body weight) in
patients with acute intermittent
porphyria
95.7 ± 3.3
The precision of the method was tested with urine
samples from a patient wich acute intermittent porphyria
and from one with porphyria cutanea tarda. Both were
tested for consistency within a series and from day to
day.
Coproporphyrin isomer III (%) in acute intermittent
porphyria:
a) in the series (n = 10), χ ± s (%) = 87.4 ± 2.6, CV = 3%;
b) from day to day (n = 10), χ ± s (%) = 87.9 ± 4.7,
CV = 5.3%.
Coproporphyrin isomers in the urine in porphyria cuta-
nea tarda
a) in the series (n = 10), χ ± s (%) = 50.2 ± 0.19, CV
= 0.38%;
b) from day to day (n = 10), χ ± s (%) = 50.3 ± 0.87,
CV= 1.73%.
The sensitivity of the method is sufficient, using cuvettes
with a 2-cm light path, to carry out an isomer analysis
with as little as 10 ng of Coproporphyrin methyl ester.
Optimum results can be obtained in the isomer analysis
of about 400 ng Coproporphyrin methyl ester.
Diagnostic characteristic data from the analysis of
Coproporphyrin I and III in both normal persons and
those with various porphyrias and lead poisoning are
presented in Table 3. When healthy subjects and patients
with acute intermittent porphyria are given exogenous
δ-aminolevulinic acid, the excretion of the porphyrin
precursors and porphyrins is magnified in the same way
as by an increase in the synthesis from endogenous
δ-aminolevulinic acid (16).
Discussion
The biosynthetic pathway of porphyrins leads to proto-
porphyrin and then to heme, but only with the isomers
of the III series. The pathway of the I isomers ends at
the level of the coproporphyrinogens or coproporphy-
rins. A completely defective enzyme in the anabolic
sequence of the porphyrin III series would be fatal, since it
would be coupled with a complete inhibition of the
. biosynthesis of the porphyrin proteins. Inferences as
to the function of the uroporphyrinogen-synthesizing
enzyme system, which is composed of the uroporphyrino-
gen I synthase and uroporphyrinogen cosynthase (uro-
porphyrinogen isomerase), may thus be drawn from the
analysis of the Coproporphyrin isomers. This enzyme
system is defective in porphyria erythropoietica conge-
nita (Morbus G nther), acute intermittent porphyria
and porphyria cutanea tarda. Furthermore, if the decar-
boxylation of higher carboxylated porphyrins to copro-
porphyrin is followed by isomer analysis, it is possible
to obtain insight into the decarboxylase system, which
has not yet been closely studied, with respect to the
enzymatic activities of the I and III isomer series.
The method described here has the important advantage
over previously published techniques in that it is
an adaptation of quantitative analysis of copropor-
phyrin isomers pre-coated thin-layer plates, which can
be evaluated both spectrophotometrically and fluori-
metrically. Furthermore, the technique of hydrolyzing
the methyl esters directly on the plate makes it possible
to analyze nanogram quantities, prevents loss of the
substances, and allows the chromatography to follow
directly upon hydrolysis.
It was thus possible to carry out routine examinations
with an acceptable expenditure of labor. Since freshly
distilled dimethylpyridine must always be used, it has
been found advantageous in practice to Chromatograph
about 20 samples simultaneously.
The results obtained (Tab. 3) agree with the most
recent literature data (compare Tables 1 and 2).
It must be emphasized that the above isomer analysis
depends on the determination of an absolute value for
the coproporphyrins. That is, the coproporphyrins
present in a biological sample are separated as the
methyl esters, isolated and their amount calculated (12),
so that the isomer analysis serves only to determine the
relative proportions. These can then be converted to
absolute amounts on the basis of the known value for
the total coproporphyrins. For this reason, we did not
determine the millimolar extinction coefficients for the
coproporphyrins I and III; if a direct quantitative or
concentration determination is undertaken, based on
the isomer analysis, (he reader is referred to the extinc-
tion coefficients of Falk (14).
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However, if the total porphyrin content is known, only
the isomeric distribution, and not the total amounts of
isomers, is of further biochemical or diagnostic interest.
In the following, a few methodological considerations
which influence the quality of the separation will be
discussed.
A 25% hydrochloric acid solution is necessary to hydro-
lyze the coproporphyrin methyl esters in the silica gel.
Experiments with less concentrated hydrochloric acid,
such as 3, 1 or 0.5 mol/1 HC1, produced only partial
hydrolysis, even when larger volumes of hydrochloric
acid were used. It is also impossible to reduce the
hydrolysis time. The quality of the separation depends
both on a complete hydrolysis of the coproporphyrin
methyl esters and on the exact composition of the sol-
vent system. If more than 7 ml distilled water is used,
and the substances are allowed to migrate over longer
distances, the separation of the isomers is impaired.
If less than 5 ml water is used, the coproporphyrins do
not leave the starting line, on account of the low polarity
of the solvent. The use of more concentrated ammonia,
i. e. 33% solution, produces a more rapid separation of
the isomers, but the bands are wavy, so that rechromato-
graphy is necessary in most cases. For the same reason, the
thin-layer plates must be placed in the chromatography
tank with their backs to the ammonia vessel.
• f
Activation of the pre-coated thin-layer plates before
and after the application of the substances had no
effect on the quality of the separation.
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